SMILES:
CC1C(C2(CCN(CC2)C3=CN=C(C(=N3)N)SC4=C(C(=NC=C4)N)Cl)CO1)N
Chemical Structure
Check the
Batoprotafib (TNO155)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
| IUPAC Name | (3S,4S)-8-[6-amino-5-[(2-amino-3-chloro-4-pyridinyl)sulfanyl]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine | |
|---|---|---|
| CAS Number | 1801765-04-7 | |
| Molecular Formula |
C18H24ClN7OS |
|
| Molecular Weight (MW) | 421.95 | |
| SMILES | CC1C(C2(CCN(CC2)C3=CN=C(C(=N3)N)SC4=C(C(=NC=C4)N)Cl)CO1)N | |
| InChIKey | UCJZOKGUEJUNIO-IINYFYTJSA-N |
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
84 mg/mL
(199.07 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 5 mg/mL |
| Water | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
- Batoprotafib (TNO155) Clinical Trials
- Batoprotafib (TNO155) Solubility in DMSO
- Batoprotafib (TNO155) Stock Solution
- Batoprotafib (TNO155) Storage
- Batoprotafib (TNO155) Stability
- Batoprotafib (TNO155) Molecular Weight
- Batoprotafib (TNO155) CAS Number
- Batoprotafib (TNO155) Chemical Structure (2D and 3D)
- Batoprotafib (TNO155) SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.